在游离DNA时代,12-13周超声扫描对胎儿先天异常早期诊断的有效性
本研究在荷兰东北部6家超声诊所和2家转诊中心开展,评估12-13周早期扫描与现行20周结构异常扫描相比,可检出的先天异常比例和类型。研究组共5534例,早期扫描检出54/85(63.5%)异常,其中结构异常23/51(45.1%)、染色体异常31/34;所有严重异常均在早期扫描检出。早期扫描假阳性率0.1%,20周扫描为0.6%。
要点
- 12-13周早期扫描可检出约半数产前可检出的结构异常及全部预期在该阶段检出的染色体异常。
- 所有严重异常(神经管缺陷、脐膨出、巨膀胱、多发严重先天及严重骨骼异常)均在早期扫描检出。
- 早期扫描假阳性率0.1%,20周扫描0.6%;超声标记检出率分别为1.4%和3.0%。
核心结论
- 由合格超声医师在12-13周进行的早期扫描可检出约半数产前可检出的结构异常及100%预期在该阶段检出的异常。
- 尤其严重的异常常导致父母选择终止妊娠,适合早期诊断;早期扫描是现代妊娠保健的重要组成部分。
研究设计与样本
- 经颈部透明层(NT)测量认证的超声医师接受额外培训后参与研究,早期扫描按结构化方案在荷兰东北部6家超声诊所和2家转诊中心进行。
- 所有选择联合试验(CT)或胎儿异常先验风险增高的孕妇被提供12-13周扫描(研究组),所有继续妊娠的孕妇按常规护理接受20周异常扫描。
- 研究组共5534例,包括选择CT的5237例和异常先验风险增高的297例。
主要发现
- 研究人群产前共检出51例结构异常和34例染色体异常,出生后另检出18例结构异常。
- 总体54/85(63.5%)异常在早期扫描检出,其中结构异常23/51(45.1%),染色体异常31/34。
- 所有严重异常均在早期扫描检出,包括全部神经管缺陷、脐膨出、巨膀胱、多发严重先天异常和严重骨骼异常。
- 早期扫描检出的23例结构异常中,12/23(52.2%)NT增高。
- 12例心脏缺陷中,4例(33.3%)在早期扫描检出,5例(41.7%)在20周扫描检出,3例(25.0%)出生后检出。
关键数值与推荐
- 早期扫描和20周扫描的假阳性诊断分别发生于0.1%和0.6%的病例。
- 早期扫描和20周扫描的超声标记分别于1.4%和3.0%的病例检出。
- 在妊娠早期或中期诊断异常后,父母选择终止妊娠的比例分别为83.3%和25.8%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The main aim of this study was to assess the proportion and type of congenital anomalies, both structural and chromosomal, that can be detected at an early scan performed at 12-13 weeks' gestation, compared with at the 20-week structural anomaly scan offered under the present screening policy. Secondary aims were to evaluate the incidence of false-positive findings and ultrasound markers at both scans, and parental choice regarding termination of pregnancy (TOP). METHODS: Sonographers accredited for nuchal translucency (NT) measurement were asked to participate in the study after undergoing additional training to improve their skills in late first-trimester fetal anatomy examination. The early scans were performed according to a structured protocol, in six ultrasound practices and two referral centers in the north-east of The Netherlands. All women opting for the combined test (CT) or with an increased a-priori risk of fetal anomalies were offered a scan at 12-13 weeks' gestation (study group). All women with a continuing pregnancy were offered, as part of the 'usual care', a 20-week anomaly scan. RESULTS: The study group consisted of 5237 women opting for the CT and 297 women with an increased a-priori risk of anomalies (total, 5534). In total, 51 structural and 34 chromosomal anomalies were detected prenatally in the study population, and 18 additional structural anomalies were detected after birth. Overall, 54/85 (63.5%) anomalies were detected at the early scan (23/51 (45.1%) structural and all chromosomal anomalies presenting with either an increased risk at first-trimester screening or structural anomalies (31/34)). All particularly severe anomalies were detected at the early scan (all cases of neural tube defect, omphalocele, megacystis, and multiple severe congenital and severe skeletal anomalies). NT was increased in 12/23 (52.2%) cases of structural anomaly detected at the early scan. Of the 12 cases of heart defects, four (33.3%) were detected at the early scan, five (41.7%) at the 20-week scan and three (25.0%) after birth. False-positive diagnoses at the early scan and at the 20-week scan occurred in 0.1% and 0.6% of cases, respectively, whereas ultrasound markers were detected in 1.4% and 3.0% of cases, respectively. After first- or second-trimester diagnosis of an anomaly, parents elected TOP in 83.3% and 25.8% of cases, respectively. CONCLUSIONS: An early scan performed at 12-13 weeks' gestation by a competent sonographer can detect about half of the prenatally detectable structural anomalies and 100% of those expected to be detected at this stage. Particularly severe anomalies, often causing parents to choose TOP, are amenable to early diagnosis. The early scan is an essential part of modern pregnancy care. Copyright © 2017 ISUOG. Published by John Wiley & Sons Ltd.
引用
- Kenkhuis MJA, Bakker M, Bardi F, et al. Effectiveness of 12-13-week scan for early diagnosis of fetal congenital anomalies in the cell-free DNA era. Ultrasound Obstet Gynecol. 2018. PMID: 28397377. doi:10.1002/uog.17487
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。